Top Articles of JCO Journals in 2024

Top Articles of JCO Journals in 2024

JCO Journals published by ASCO are a range of peer-reviewed journals that are essential for disseminating the latest research and clinical practices in oncology. These include:

  • Journal of Clinical Oncology (JCO): The flagship journal featuring original research articles on cancer treatment and care.
  • JCO Oncology Practice: Focuses on practical aspects of oncology practice.
  • JCO Global Oncology: Addresses cancer care challenges in low-resource settings.
  • JCO Precision Oncology: Concentrates on genomics-driven cancer care
  • JCO Clinical Cancer Informatics: Publishes research on biomedical informatics related to cancer data.
  • JCO Oncology Advances: An online-only open-access journal dedicated to cutting-edge global clinical and translational research in oncology.

ASCO has presented the Top 5 articles from each JCO Journal:

Journal of Clinical Oncology

1. Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Authors: Funda Meric-Bernstam et al

2. Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Authors: Fred Saad et al

3. Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study

Authors: Benjamin J. Solomon et al

4. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

Authors: Julio Garcia-Aguilar et al

5. Scotch and Pizza

Authors: Paul S. Jansson

JCO Oncology Practice

1. Social Determinants of Health and Cancer Care: An ASCO Policy Statement

Authors: Azam Masood et al

2. ‘Patient Is Otherwise Healthy’

Authors: Scott J. Capozza

3. Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data

Authors: Jeffrey A. Scott et al

4. Breast Cancer Brain Metastasis: A Comprehensive Review

Authors: Nuhad K. Ibrahim et al

5. Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Authors: Shipra Gandhi et al

JCO Global Oncology

1. Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource–Stratified Guideline

Authors: Sana Al Sukhun et al.

2. Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India

Authors: Aju Mathew et al

3. Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study)

Authors: Venkatraman Radhakrishnan et al

4. Latin American Consensus on the Treatment of Head and Neck Cancer

Authors: Leandro Luongo Matos et al

5. Consensus-Based Guidelines for Acute Myeloid Leukemia Management in Gulf Cooperation Council Countries: Addressing Unmet Regional Needs and the Changing AML Landscape

Authors: Al-Khabori et al

JCO Precision Oncology

1. Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care

Authors: Lauren C. Leiman et al

2. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer

Authors: Jacqueline A. Shaw et al

3. Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer

Authors: David R. Gandara et al

4. Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors

Authors: Channing J. Paller et al

5. Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives

Authors: Sally L. George et al

JCO Clinical Cancer Informatics

1. Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data

Authors: Levente Lippenszky et al

2. Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions

Authors: Emily H. Castellanos et al

3. Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Chemotherapy

Authors: Brittany A. McKelvey et al

4. Pancreatic Cancer Action Network’s SPARK: A Cloud-Based Patient Health Data and Analytics Platform for Pancreatic Cancer

Authors: Kawther Abdilleh et al

5. Characterizing the Increase in Artificial Intelligence Content Detection in Oncology Scientific Abstracts From 2021 to 2023

Authors: Frederick M. Howard et al

JCO Oncology Advances

1. Small Cell Lung Cancer: New Hope, New Challenges

Authors: Parth Desai et al

2. Clinical Outcomes and Efficacy of Human Epidermal Growth Factor Receptor 2–Targeted Therapy in Breast Cancer With Uncommon In Situ Hybridization Patterns or Discordant Immunohistochemistry

Authors: Qianchen Zhang et al

3. Examining Racial Disparities in the Association Between Food Swamps and Early-Onset Colorectal Cancer Mortality

Authors: Malcolm Bevel et al

4. Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings From the Friends’ HRD Harmonization Project

Authors: Hillary S. Andrews et al

5. Neoadjuvant Atezolizumab in Patients With Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

Authors: Vasu Divi et al

These articles reflect the latest advancements in oncology research, showcasing innovative studies that have the potential to transform cancer treatment and improve patient outcomes.